We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · June 14, 2020

High Serum Free IL-18 Is Associated With Decreased Omalizumab Efficacy

The Journal of Asthma : Official Journal of the Association for the Care of Asthma

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Journal of Asthma : Official Journal of the Association for the Care of Asthma
High Serum Free IL-18 Is Associated With Decreased Omalizumab Efficacy: Findings From a 2-Year Omalizumab Treatment Study
J Asthma 2020 May 20;[EPub Ahead of Print], C Morimoto, H Matsumoto, T Tajiri, Y Gon, R Ito, S Hashimoto, M Suzukawa, K Ohta, K Izuhara, J Ono, S Ohta, I Ito, T Oguma, Y Kanemitsu, T Nagasaki, Y Izuhara, A Niimi, T Hirai

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading